Cardiff Oncology Inc (CRDF)
3.30
-0.16
(-4.62%)
USD |
NASDAQ |
May 07, 11:09
Cardiff Oncology Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2018 | 69.81% |
| June 30, 2018 | -82.84% |
| March 31, 2018 | -265.8% |
| December 31, 2017 | -107.3% |
| September 30, 2017 | -283.7% |
| June 30, 2017 | -231.5% |
| March 31, 2017 | -548.6% |
| December 31, 2016 | -762.6% |
| Date | Value |
|---|---|
| September 30, 2016 | -376.4% |
| June 30, 2016 | -296.0% |
| March 31, 2016 | -156.7% |
| December 31, 2015 | -151.6% |
| September 30, 2015 | -202.7% |
| June 30, 2015 | -36.74% |
| March 31, 2015 | -38.95% |
| December 31, 2014 | 72.62% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| BioVie Inc | -- |
| Perspective Therapeutics Inc | -- |
| Biolase Inc | 26.12% |
| Tenon Medical Inc | 69.18% |
| Adial Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -51.37% |
| Return on Assets | -44.89% |
| Return on Invested Capital | -51.37% |
| Profit Margin (Quarterly) | -4.88K% |
| Operating Margin (Quarterly) | -5.33K% |
| Return on Net Operating Assets | -1.16K% |